Search - tctmd.com

Displaying 321 - 340 of 616

Sort: Relevancy | Date

Presentation TVT 2019

Controversies Around PPM: Its Estimation and When Does it Matter?

Presenter: Philippe Pibarot

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Cracking, Fracturing, and Fracking Bioprosthetic Valves

Presenter: Adnan Chhatriwalla

June 13, 2019

Presentation TVT 2019

A Tutorial on Surgical Bioprosthesis Design: Impact on VIV Therapy

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Updates on SAPIEN Balloon-Expandable VIV

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Ventricular Septal Defect Associated With Bioprosthetic Valve Fracturing

Presenter: Albert Chan

June 13, 2019

Presentation TVT 2019

Percutaneous Transeptal Mitral Valve Implantation in Failed Bioprosthetic Valves Without Fluoroscopic Landmarks

Presenter: Pedro Nicz

June 13, 2019

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

Presentation CIT 2019

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Presenter: David Zhao

March 28, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

Advertisement

Controversies Around PPM: Its Estimation and When Does it Matter?

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Cracking, Fracturing, and Fracking Bioprosthetic Valves

A Tutorial on Surgical Bioprosthesis Design: Impact on VIV Therapy

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Updates on SAPIEN Balloon-Expandable VIV

Ventricular Septal Defect Associated With Bioprosthetic Valve Fracturing

Percutaneous Transeptal Mitral Valve Implantation in Failed Bioprosthetic Valves Without Fluoroscopic Landmarks

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Latest Observational Data Support TAVR Durability Through 7 Years

TAVR for Failed Aortic Bioprosthetic Surgical Valves: Clinical Overview

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content